U.S. Entertainment Stock News

NasdaqGS:TSLA
NasdaqGS:TSLAAuto

Assessing Whether Tesla (TSLA) Looks Undervalued After Mixed Recent Share Price Performance

Tesla stock reaction overview Tesla (TSLA) recently closed at US$426.01, with the stock showing mixed short term performance, including gains over the past month and past 3 months but a decline year to date. See our latest analysis for Tesla. The recent 1 month share price return of 13.21% contrasts with a year to date decline of 2.75%, while the 1 year total shareholder return of 25.54% reflects longer term momentum still in place. If Tesla has sharpened your interest in fast changing tech,...
NYSE:LZB
NYSE:LZBConsumer Durables

Is It Time To Reconsider La-Z-Boy (LZB) After Recent Share Price Weakness

If you have ever looked at La-Z-Boy and wondered whether the current share price offers fair value or a mispricing opportunity, this breakdown is for you. The stock last closed at US$36.65, with returns of 6.9% over the past week, 3.5% over the past month, a year to date decline of 1.7%, and a 1 year decline of 10.5%. The 3 year return stands at 45.6% and the 5 year return is a 0.9% decline. These mixed returns mean recent headlines and company updates matter for how investors are...
NYSE:FRO
NYSE:FROOil and Gas

A Look At Frontline (NYSE:FRO) Valuation After Record Profits Dividend And Fleet Expansion

Frontline (NYSE:FRO) is back in focus after reporting record first quarter profits and revenue, tied to elevated tanker rates and disruption from the Strait of Hormuz closure, alongside a sizeable cash dividend and fleet expansion. See our latest analysis for Frontline. The share price has pulled back 3.4% in the last day to $37.12 after record quarterly results and a sizeable dividend. However, a 1 month share price return of 4.3% and a very large 5 year total shareholder return suggest...
NasdaqGS:QFIN
NasdaqGS:QFINConsumer Finance

A Look At Qfin Holdings (QFIN) Valuation After A Year Of Weak Shareholder Returns

Qfin Holdings stock reaction and recent performance snapshot Qfin Holdings (NasdaqGS:QFIN) has drawn investor attention after a period of pressure on the share price, with the stock down 10% over the past month and 20% over the past 3 months. See our latest analysis for Qfin Holdings. Zooming out, the recent share price pressure fits into a tougher stretch overall, with the stock down 38.85% year to date on a share price basis and the 1 year total shareholder return down 70.21%, although the...
NasdaqGS:COIN
NasdaqGS:COINCapital Markets

Why Coinbase Global (COIN) Is Down 5.3% After AI-Focused Layoffs and Restructuring Charges

Earlier this week, Coinbase Global announced plans to cut about 14% of its workforce, taking up to US$60.00 million in restructuring charges as it reorganizes into smaller, more integrated teams to respond to volatile markets and rapid advances in artificial intelligence. CEO Brian Armstrong framed the layoffs as a structural reset aimed at simplifying management layers and reshaping Coinbase’s cost base to align with AI-driven changes across the crypto and fintech industry. We’ll now...
NYSE:LYV
NYSE:LYVEntertainment

Did Live Nation's New Spotify-Powered “Reserved” Tickets Just Recast LYV's Tech and Fan-Trust Narrative?

Live Nation Entertainment recently launched “Reserved,” a new ticketing access program for eligible Spotify Premium subscribers in the US, aiming to cut competition and stress in buying concert tickets without extra fees from Spotify. This collaboration highlights how Live Nation is experimenting with partner-driven ticket access to address fan frustration and rebuild trust around ticketing. Next, we’ll examine how the Reserved initiative with Spotify could influence Live Nation’s investment...
NasdaqGM:LNTH
NasdaqGM:LNTHMedical Equipment

Is It Too Late To Consider Lantheus Holdings (LNTH) After Its Strong Share Price Run?

This article is designed to help you think through whether Lantheus Holdings, at around US$103, is still offering value or if most of the opportunity is already priced in. The stock has shown strong recent price action, with returns of 9.7% over the past week, 22.1% over the past month, 53.1% year to date, and 39.5% over the past year. Recent coverage has focused on Lantheus as a specialist in medical imaging and diagnostics, with investors closely watching how its product portfolio...
NasdaqGS:INTA
NasdaqGS:INTASoftware

Intapp Expands AI Timekeeping As Shares Trade Below Analyst Targets

Intapp (NasdaqGS:INTA) has introduced new AI powered features in Intapp Time, focused on helping professional services firms manage time and revenue capture more efficiently. The latest release includes AI work code prediction, configurable narrative tone enforcement, and upgraded mobile timekeeping tools. The update expands the use of AI across Intapp's cloud product suite for professional services clients. Intapp operates in the professional services technology space, where firms depend...
NasdaqGS:AMD
NasdaqGS:AMDSemiconductor

Advanced Micro Devices (AMD) Is Up 10.2% After $10 Billion Taiwan AI Chip Capacity Bet - What's Changed

Earlier this week, AMD confirmed it is ramping production of its next‑generation 2nm EPYC “Venice” processors with TSMC in Taiwan, while also committing more than US$10.00 billion to expand advanced packaging and AI manufacturing capacity across Taiwan’s semiconductor ecosystem. The move makes Venice the first high‑performance computing product produced on TSMC’s 2nm node and tightens AMD’s partnerships across foundry, packaging and system integrators, potentially reinforcing its role at the...
NasdaqGS:ALMS
NasdaqGS:ALMSPharmaceuticals

How Alumis’ Revenue Slide but Smaller Per-Share Loss Will Impact Alumis (ALMS) Investors

Alumis Inc. recently reported its first-quarter 2026 results, with revenue of US$1.74 million compared with US$17.39 million a year earlier and a net loss of US$93.05 million versus US$98.96 million. Despite the sharp revenue drop, the company narrowed its basic loss per share from continuing operations to US$0.74, down from US$1.82, highlighting shifting cost and earnings dynamics. Next, we’ll examine how Alumis’s sharply lower revenue but reduced loss per share shapes the company’s broader...
NYSE:RVTY
NYSE:RVTYLife Sciences

Is It Time To Reassess Revvity (RVTY) After Its Recent Share Price Rebound?

Wondering whether Revvity at about US$96.95 is offering fair value or a potential mispricing opportunity? This article walks through the key signals to help you frame that question clearly. The stock has recently gained 3.2% over the last 7 days and 11.7% over the last 30 days, even though it is still down 1.2% year to date. Its 3 year and 5 year returns of 16.2% and 32.4% respectively are also in decline. Recent coverage has focused on Revvity’s position within life sciences and...
NYSE:ANET
NYSE:ANETCommunications

Arista Networks (ANET) Is Up 8.5% After AI-Focused Beat, Guidance Hike And Gartner Leadership Gains

In recent weeks, Arista Networks has reported strong first-quarter 2026 results, raised its full-year growth and AI-centric revenue outlook, and been recognized as a Leader in Gartner’s 2026 Magic Quadrant for Enterprise Wired and Wireless LAN while launching new ruggedized switches and advanced AI-driven network operations tools. An interesting angle is how Arista is pairing its AI data center positioning with an expanding enterprise campus portfolio, potentially broadening its role from...
NasdaqCM:TGTX
NasdaqCM:TGTXBiotechs

Assessing TG Therapeutics (TGTX) Valuation After Higher 2026 Revenue Guidance And Briumvi Momentum

Revenue guidance update and Briumvi sales momentum TG Therapeutics (TGTX) recently lifted its 2026 revenue expectations after reporting better than expected sales of its multiple sclerosis drug Briumvi, a shift that has drawn fresh attention to the stock. The company’s shares are up about 29% over the past 3 months, with investors also watching upcoming clinical readouts as TG Therapeutics tests Briumvi in additional autoimmune indications and seeks to refine how the drug is administered. See...
NYSE:NIQ
NYSE:NIQMedia

A Look At NIQ Global Intelligence’s Valuation After Recent Share Price Weakness

NIQ Global Intelligence (NIQ), a Chicago based consumer intelligence company, is drawing investor attention after recent share price moves, with the stock down about 26% over the past month and 23% over the past 3 months. See our latest analysis for NIQ Global Intelligence. Those short term moves sit within a tougher year for shareholders, with the 30 day share price return down 26% and the year to date share price return down 46%. This points to fading momentum despite a recent 7 day...
NasdaqGS:TTWO
NasdaqGS:TTWOEntertainment

Is It Time To Reconsider Take Two Interactive Software (TTWO) After Recent Share Price Pullback?

If you are trying to figure out whether Take-Two Interactive Software stock is genuinely good value or just riding on expectations, it helps to start with how the current price lines up against different valuation checks. The stock last closed at US$227.55, with the share price down 6.1% over the past week, up 8.0% over the past month, slightly up 1.1% over the last year and up 63.7% over three years, while the year to date return is down 9.6%. These mixed returns put more attention on what...
NYSE:NKE
NYSE:NKELuxury

Is Nike (NKE) Worth A Fresh Look After This Week’s 6.7% Share Price Jump?

For investors considering whether NIKE at around US$44.67 represents value or added volatility, this article walks through key signals so you can evaluate the stock on its price tag rather than its brand. The stock has risen 6.7% over the past week, while year to date it is down 29.4% and over the past year it is down 23.7%. These moves may prompt investors to reassess both risk and potential upside. Recent headlines have focused on NIKE's position in the athleticwear market, including...
NYSE:MOD
NYSE:MODBuilding

Modine’s Performance Technologies Spin-Off and Gentherm Deal Could Be A Game Changer For MOD

In recent days Modine Manufacturing has prepared for its upcoming fourth-quarter fiscal 2026 earnings release while advancing plans to spin off its Performance Technologies business into a separate company with Gentherm, aiming to sharpen its focus on higher-margin Climate Solutions operations. At the same time, a series of largely administrative insider share disposals for tax withholding and new restricted stock unit awards has highlighted how leadership compensation is increasingly...
NYSE:TEN
NYSE:TENOil and Gas

A Look At Tsakos Energy Navigation (TEN) Valuation After Q1 2026 Earnings Beat And Dividend Hike

Tsakos Energy Navigation (TEN) is back in focus after Q1 2026 results and a fresh dividend move, reporting earnings per share of US$2.72 and the highest common dividend in more than a decade. See our latest analysis for Tsakos Energy Navigation. Despite the Q1 beat and higher dividend, Tsakos Energy Navigation’s share price has eased 4.2% in the last day. However, the 30 day share price return of 8.5% and year to date gain of 94.7% signal strong momentum, supported by a 1 year total...
NYSE:IVZ
NYSE:IVZCapital Markets

Did Routine Grants and ETF Payouts Quietly Highlight Invesco’s (IVZ) Leverage and Growth Trade-offs?

In May 2026, multiple Invesco Ltd. directors received routine equity-based compensation grants of 8,112 Common Shares each, while Invesco Canada announced May cash distributions across its ETF lineup for unitholders of record on May 28 with payments scheduled for June 5. Alongside these governance and income developments, fresh coverage has highlighted concerns about Invesco’s stagnant sales, elevated leverage, and potential overvaluation pressures, as well as modest ETF market share...
NYSE:LAZ
NYSE:LAZCapital Markets

Is Lazard’s (LAZ) Expansion-Driven Strategy Diluting the Payoff From Its Latest Revenue Gains?

Lazard recently reported first-quarter results showing year-on-year revenue growth but falling short of analyst expectations, while emphasizing its acquisition of Campbell Lutyens as a step toward building a more productive, growth-oriented firm. Alongside these mixed earnings, Lazard confirmed a June 2026 distribution from its Global Total Return and Income Fund and outlined upcoming investor outreach, offering a broader view of how it is positioning both its advisory and asset management...
NYSE:CLF
NYSE:CLFMetals and Mining

Why Cleveland-Cliffs (CLF) Is Up 8.9% After GM Award and Reaffirmed 2026 Outlook

Cleveland-Cliffs recently received General Motors’ 2025 Supplier of the Year award, its ninth such honor and the only recognition given to a North American steel producer, while also reporting a narrower first-quarter adjusted loss than expected and reaffirming its full-year 2026 outlook. This combination of reaffirmed guidance and renewed validation from a major automotive customer highlights Cleveland-Cliffs’ entrenched role in North American auto steel supply chains at a time when some...
NYSE:AMH
NYSE:AMHResidential REITs

American Homes 4 Rent (AMH) Valuation Check After Analyst Upgrade And Dividend Affirmation

Dividend declarations put American Homes 4 Rent in focus American Homes 4 Rent (AMH) has drawn fresh investor attention after affirming its common and preferred dividends, alongside a recent analyst upgrade and improving data on US homebuilder confidence. See our latest analysis for American Homes 4 Rent. At a share price of US$32.27, American Homes 4 Rent has seen a 9.69% 90 day share price return and a 1 year total shareholder return that declined 10.94%. This suggests that recent momentum...
NasdaqGS:SNDX
NasdaqGS:SNDXBiotechs

Did New Revuforj Post‑Transplant Data at ASCO 2026 Just Shift Syndax Pharmaceuticals' (SNDX) Investment Narrative?

Syndax Pharmaceuticals recently announced that four Revuforj (revumenib) abstracts were accepted for presentation at the ASCO 2026 meeting, including new post‑transplant maintenance and pharmacokinetic data in acute leukemia. A particularly important element is the oral presentation comparing survival and relapse outcomes for revumenib-treated post‑transplant patients against a historical cohort, offering an early real‑world benchmark for the drug’s clinical impact. We’ll now examine how the...
NasdaqGS:PLPC
NasdaqGS:PLPCElectrical

A Look At Preformed Line Products (PLPC) Valuation After Strong Price Gains And Overvaluation Signals

Preformed Line Products (PLPC) shares recently climbed 4.9% on what is described as strong company performance, even as the stock is flagged as significantly overvalued relative to its estimated intrinsic value by GF Value assessments. See our latest analysis for Preformed Line Products. That 4.9% one day share price return comes on top of a 40.3% 90 day share price return and a 1 year total shareholder return of 159.9%, indicating recent momentum even as valuation appears stretched. If...